This study focused on a ceRNA network to provide a novel perspective and insight into endometrial cancer and suggested that the signature based on LINC00491, LINC00483, ADARB2-AS1, and C8orf49 could serve as an independent prognostic biomarker in endometrial cancer. The gene discussed is ADARB2; the disease is endometrial cancer.